Stockreport

Why Amphastar Pharmaceuticals (AMPH) Is Up 8.4% After Strong Q3 Revenue and Key FDA Approvals [Yahoo! Finance]

Amphastar Pharmaceuticals, Inc.  (AMPH) 
Last amphastar pharmaceuticals, inc. earnings: 3/12 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.amphastar.com/investor-relations
PDF of US$17.35 million, with sales of Baqsimi and Primatene Mist contributing to performance and recent pipeline and product expansion announced. Despite a dip in profits [Read more]